Simian	O
virus	O
40	O
large	O
T	O
antigen	O
and	O
two	O
independent	O
T	O
-	O
antigen	O
segments	O
sensitize	O
cells	B-Cell
to	O
apoptosis	O
following	O
genotoxic	O
damage	O
.	O

The	O
simian	O
virus	O
40	O
(	O
SV40	O
)	O
large	O
tumor	O
(	O
T	O
)	O
antigen	O
is	O
sufficient	O
to	O
transform	O
cells	B-Cell
in	O
cultures	O
and	O
induce	O
tumors	B-Cancer
in	O
experimental	O
animals	O
.	O

Transformation	O
of	O
primary	O
cells	B-Cell
in	O
cultures	O
requires	O
both	O
overcoming	O
growth	O
arrest	O
by	O
stimulating	O
the	O
cell	B-Cell
cycle	O
and	O
blocking	O
cell	B-Cell
death	O
activities	O
presumably	O
activated	O
by	O
oncogene	O
-	O
mediated	O
hyperproliferation	O
signals	O
.	O

The	O
study	O
presented	O
here	O
examined	O
the	O
ability	O
of	O
specific	O
regions	O
and	O
activities	O
of	O
T	O
antigen	O
to	O
modulate	O
apoptosis	O
in	O
cells	B-Cell
treated	O
with	O
the	O
genotoxic	O
agent	O
5	O
-	O
fluorouracil	O
(	O
5	O
-	O
FU	O
)	O
.	O

The	O
results	O
showed	O
that	O
the	O
expression	O
of	O
full	O
-	O
length	O
T	O
antigen	O
rendered	O
rat	O
embryo	B-Cell
fibroblasts	I-Cell
(	O
REF	B-Cell
)	O
sensitive	O
to	O
5	O
-	O
FU	O
-	O
induced	O
apoptosis	O
.	O

Thus	O
,	O
neither	O
the	O
p53	O
-	O
binding	O
region	O
nor	O
the	O
Bcl	O
-	O
2	O
homology	O
region	O
of	O
T	O
antigen	O
was	O
sufficient	O
to	O
prevent	O
cell	B-Cell
death	O
induced	O
by	O
the	O
DNA	O
-	O
damaging	O
agent	O
.	O

T	O
-	O
antigen	O
-	O
mediated	O
sensitization	O
occurred	O
independently	O
of	O
retinoblastoma	O
protein	O
or	O
p53	O
and	O
p300	O
binding	O
.	O

An	O
N	O
-	O
terminal	O
segment	O
containing	O
the	O
first	O
127	O
T	O
-	O
antigen	O
amino	O
acids	O
(	O
T1	O
-	O
127	O
)	O
was	O
sufficient	O
to	O
sensitize	O
cells	B-Cell
.	O

A	O
C	O
-	O
terminal	O
segment	O
consisting	O
of	O
T	O
-	O
antigen	O
amino	O
acids	O
251	O
to	O
708	O
(	O
T251	O
-	O
708	O
)	O
also	O
sensitized	O
cells	B-Cell
to	O
5	O
-	O
FU	O
-	O
induced	O
apoptosis	O
.	O

This	O
sensitization	O
did	O
not	O
occur	O
when	O
T251	O
-	O
708	O
was	O
targeted	O
to	O
the	O
nucleus	B-Cellular_component
by	O
inclusion	O
of	O
the	O
SV40	O
nuclear	B-Cellular_component
localization	O
signal	O
.	O

The	O
introduction	O
of	O
mutations	O
into	O
the	O
T	O
-	O
antigen	O
J	O
domain	O
resulted	O
in	O
mutation	O
-	O
specific	O
and	O
variable	O
inhibition	O
of	O
apoptosis	O
.	O

This	O
result	O
suggested	O
that	O
either	O
the	O
structural	O
or	O
the	O
functional	O
integrity	O
of	O
the	O
J	O
domain	O
is	O
required	O
to	O
sensitize	O
cells	B-Cell
to	O
apoptosis	O
.	O

Treatment	O
of	O
REF	B-Cell
or	O
REF	B-Cell
expressing	O
full	O
-	O
length	O
T	O
antigen	O
,	O
an	O
N	O
-	O
terminal	O
segment	O
,	O
or	O
T251	O
-	O
708	O
resulted	O
in	O
increased	O
expression	O
of	O
the	O
p53	O
-	O
responsive	O
MDM2	O
gene	O
;	O
apoptosis	O
occurred	O
through	O
a	O
p53	O
-	O
dependent	O
pathway	O
,	O
as	O
p53	B-Cell
-	I-Cell
null	I-Cell
cells	I-Cell
expressing	O
these	O
T	O
antigens	O
were	O
resistant	O
to	O
5	O
-	O
FU	O
-	O
induced	O
apoptosis	O
.	O

Possible	O
mechanisms	O
involved	O
in	O
sensitizing	O
cells	B-Cell
to	O
a	O
p53	O
-	O
dependent	O
apoptosis	O
pathway	O
in	O
spite	O
of	O
the	O
ability	O
of	O
T	O
antigen	O
to	O
bind	O
and	O
inactivate	O
the	O
transcriptional	O
transactivating	O
activity	O
of	O
p53	O
are	O
discussed	O
.	O

